| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3000337 |
| Synonym(s) | AR-100 RO-48-2622 |
| Definition | Iclaprim is a bactericidal compound that inhibits dihydrofolate reductase. It is used against clinically important Gram-positive pathogens, including methicillin-sensitive Staphylococcus aureus and methicillin-resistant S. aureus. |
| SMILES | COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)OC(C1CC1)C=C2 |
| PubChem | 213043 |
| ChEMBL | CHEMBL134561 |
| ChEBI | 31724 |
| CAS | 192314-93-5 |
| Drug Class | diaminopyrimidine antibiotic |
| Classification | 2 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show + diaminopyrimidine antibiotic [Drug Class] |
| Sub-Term(s) | 2 ontology terms | Show + antibiotic sensitive dihydrofolate reductase targeted_by_antibiotic + dfrL confers_resistance_to_antibiotic |
| Publications | Oefner C, et al. 2009. Acta Crystallogr D Biol Crystallogr 65(PT 8): 751-757. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus. (PMID 19622858) Sader HS, et al. 2009. Antimicrob Agents Chemother 53(5): 2171-2175. Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates. (PMID 19289528) |
| Curator | Description | Most Recent Edit |
|---|